Table 1.
Baseline characteristics
| Case | Sex | Age (yr) | Operation method to treat pancreatic cancer | Histology | Stage | Adjuvant chemotherapy |
|---|---|---|---|---|---|---|
| 1 | M | 64 | DP | Tubular adenocarcinoma | IB | GEM |
| 2 | M | 65 | PD | Tubular adenocarcinoma | IIA | GEM |
| 3 | F | 64 | DP | Tubular adenocarcinoma | IV | S-1 |
| 4 | F | 63 | PPPD | Tubular adenocarcinoma | IIA | GEM |
| 5 | M | 65 | PD | Tubular adenocarcinoma | Unknown | S-1 |
| 6 | F | 74 | DP | Intraductal papillary-mucinous carcinoma | IV | GEM |
DP, distal pancreatectomy; GEM, gemcitabine; PD, pancreatoduodenectomy; PPPD, pylorus-preserving pancreatoduodenectomy.